158 related articles for article (PubMed ID: 32805237)
1. It Takes a Village…: Contending With Drug Shortages During Disasters.
Burry LD; Barletta JF; Williamson D; Kanji S; Maves RC; Dichter J; Christian MD; Geiling J; Erstad BL
Chest; 2020 Dec; 158(6):2414-2424. PubMed ID: 32805237
[TBL] [Abstract][Full Text] [Related]
2. Managing medication supply chains: Lessons learned from Taiwan during the COVID-19 pandemic and preparedness planning for the future.
Kuo S; Ou HT; Wang CJ
J Am Pharm Assoc (2003); 2021; 61(1):e12-e15. PubMed ID: 32919923
[TBL] [Abstract][Full Text] [Related]
3. Sedation, Analgesia, and Paralysis in COVID-19 Patients in the Setting of Drug Shortages.
Ammar MA; Sacha GL; Welch SC; Bass SN; Kane-Gill SL; Duggal A; Ammar AA
J Intensive Care Med; 2021 Feb; 36(2):157-174. PubMed ID: 32844730
[TBL] [Abstract][Full Text] [Related]
4. Collaborative Management Strategies for Drug Shortages in Neurocritical Care.
Clark SL; Levasseur-Franklin K; Pajoumand M; Barra M; Armahizer M; Patel DV; Wyatt Chester K; Tully AP
Neurocrit Care; 2020 Feb; 32(1):226-237. PubMed ID: 31077080
[TBL] [Abstract][Full Text] [Related]
5. National drug shortages worsen during COVID-19 crisis: Proposal for a comprehensive model to monitor and address critical drug shortages.
Piatek OI; Ning JC; Touchette DR
Am J Health Syst Pharm; 2020 Oct; 77(21):1778-1785. PubMed ID: 32716030
[TBL] [Abstract][Full Text] [Related]
6. Clinical dilemmas and a review of strategies to manage drug shortages.
Rider AE; Templet DJ; Daley MJ; Shuman C; Smith LV
J Pharm Pract; 2013 Jun; 26(3):183-91. PubMed ID: 23553544
[TBL] [Abstract][Full Text] [Related]
7. Strategic plan aims to curb drug shortages.
Cancer Discov; 2014 Jan; 4(1):7. PubMed ID: 24402927
[TBL] [Abstract][Full Text] [Related]
8. Stress and strain on the U.S. drug supply: The intersection of shortages, globalization, counterfeit products, and throw in a global COVID-19 pandemic.
Farmer KC
J Am Pharm Assoc (2003); 2021; 61(1):e85-e86. PubMed ID: 33419525
[No Abstract] [Full Text] [Related]
9. Drug shortages: a complex health care crisis.
Fox ER; Sweet BV; Jensen V
Mayo Clin Proc; 2014 Mar; 89(3):361-73. PubMed ID: 24582195
[TBL] [Abstract][Full Text] [Related]
10. Shortage of sedatives and neuromuscular blockers during COVID-19 pandemic: The result of an overstocking procedure in French hospitals?
Montmeat D; Gard C; Raux M; Constantin JM; Tilleul P
Anaesth Crit Care Pain Med; 2020 Oct; 39(5):585-586. PubMed ID: 32654910
[No Abstract] [Full Text] [Related]
11. Mechanical-Ventilation Supply and Options for the COVID-19 Pandemic. Leveraging All Available Resources for a Limited Resource in a Crisis.
Dar M; Swamy L; Gavin D; Theodore A
Ann Am Thorac Soc; 2021 Mar; 18(3):408-416. PubMed ID: 33202144
[TBL] [Abstract][Full Text] [Related]
12. A Commons for a Supply Chain in the Post-COVID-19 Era: The Case for a Reformed Strategic National Stockpile.
Handfield R; Finkenstadt DJ; Schneller ES; Godfrey AB; Guinto P
Milbank Q; 2020 Dec; 98(4):1058-1090. PubMed ID: 33135814
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of concomitant use of enteral and intravenous sedatives and analgesics in mechanically ventilated patients with COVID-19.
Kang N; Alrashed MA; Place EM; Nguyen PT; Perona SJ; Erstad BL
Am J Health Syst Pharm; 2022 Feb; 79(Suppl 1):S21-S26. PubMed ID: 34597357
[TBL] [Abstract][Full Text] [Related]
14. The Drug Shortage Crisis in the United States: Impact on Cancer Pharmaceutical Safety.
Nonzee NJ; Luu TH
Cancer Treat Res; 2019; 171():75-92. PubMed ID: 30552658
[TBL] [Abstract][Full Text] [Related]
15. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
[TBL] [Abstract][Full Text] [Related]
16. Business and continuity of operations: care of the critically ill and injured during pandemics and disasters: CHEST consensus statement.
Tosh PK; Feldman H; Christian MD; Devereaux AV; Kissoon N; Dichter JR; ;
Chest; 2014 Oct; 146(4 Suppl):e103S-17S. PubMed ID: 25144857
[TBL] [Abstract][Full Text] [Related]
17. Drug shortages in the United States: a critical evaluation of root causes and the need for action.
Gupta DK; Huang SM
Clin Pharmacol Ther; 2013 Feb; 93(2):133-5. PubMed ID: 23337520
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
[TBL] [Abstract][Full Text] [Related]
19. Global drug shortages due to COVID-19: Impact on patient care and mitigation strategies.
Badreldin HA; Atallah B
Res Social Adm Pharm; 2021 Jan; 17(1):1946-1949. PubMed ID: 32446652
[TBL] [Abstract][Full Text] [Related]
20. Obama takes action on drugs shortages.
Roehr B
BMJ; 2011 Nov; 343():d7158. PubMed ID: 22051520
[No Abstract] [Full Text] [Related]
[Next] [New Search]
